1. Hemodynamic monitoring by intracardiac impedance measured by cardiac resynchronization defibrillators: Evaluation in a controlled clinical setting (BIO.Detect HF II study)
- Author
-
Niels Eske Bruun, Christoph Stellbrink, Sebastian Maier, Klaus-Jürgen Gutleben, Peter Søgaard, Hanno Oswald, Stefan Paule, Peter-Paul Henri Marie Delnoy, and Jens Brock Johansen
- Subjects
medicine.medical_specialty ,CRT, cardiac resynchronization therapy ,medicine.medical_treatment ,Stroke impedance ,Cardiac resynchronization therapy ,Hemodynamics ,Heart failure ,030204 cardiovascular system & hematology ,Hemodynamic parameters ,HF, heart failure ,Intracardiac injection ,03 medical and health sciences ,QRS complex ,0302 clinical medicine ,Cardiac resynchronization therapy defibrillator ,Physiology (medical) ,Internal medicine ,EDZ, end-diastolic impedance ,medicine ,Diseases of the circulatory (Cardiovascular) system ,030212 general & internal medicine ,SZ, stroke impedance ,cardiovascular diseases ,NYHA, New York Heart Association ,Stroke ,LV, left ventricular ,Ejection fraction ,business.industry ,ICI, intracardiac impedance ,Ao-VTI, aortic velocity time integral ,Stroke volume ,ICI-MF, ICI measurement feature ,medicine.disease ,LVEDD, LV end-diastolic diameter ,Zmean, mean impedance ,ESZ, end-systolic impedance ,LVEF, LV ejection fraction ,RC666-701 ,Cardiology ,cardiovascular system ,CRT-D, CRT defibrillator ,Original Article ,Intracardiac impedance ,Cardiology and Cardiovascular Medicine ,business ,RV, right ventricular - Abstract
Background In patients with cardiac resynchronization therapy defibrillators (CRT-Ds), intracardiac impedance measured by dedicated CRT-D software may be used to monitor hemodynamic changes. We investigated the relationship of hemodynamic parameters assessed by intracardiac impedance and by echocardiography in a controlled clinical setting. Methods The study enrolled 68 patients (mean age, 66 ± 9 years; 74% males) at 12 investigational sites. The patients had an indication for CRT-D implantation, New York Heart Association class II/III symptoms, left ventricular ejection fraction 15%–35%, and a QRS duration ≥150 ms. Two months after a CRT-D implantation, hemodynamic changes were provoked by overdrive pacing. Intracardiac impedance was recorded at rest and at four pacing rates ranging from 10 to 40 beats/min above the resting rate. In parallel, echocardiography measurements were performed. We hypothesized that a mean intra-individual correlation coefficient (rmean) between stroke impedance (difference between end-systolic and end-diastolic intracardiac impedance) measured by CRT-D and the aortic velocity time integral (i.e., stroke volume) determined by echocardiography would be significantly larger than 0.65. Results The hypothesis was evaluated in 40 patients with complete data sets. The rmean was 0.797, with a lower confidence interval bound of 0.709. The study hypothesis was met (p = 0.007). A stepwise reduction of stroke impedance and stroke volume was observed with increasing heart rate. Conclusions Intracardiac impedance measured by implanted CRT-Ds correlated well with the aortic velocity time integral (stroke volume) determined by echocardiography. The impedance measurements bear potential and are readily available technically, not requiring implantation of additional material beyond standard CRT-D system., Highlights • Intracardiac impedance measurement feature (ICI-MF) is integrated in some CRT-Ds. • We studied relationship between echo hemodynamic parameters and ICI-MF of CRT-Ds. • Stroke volume by echo correlated well with stroke impedance by ICI-MF of CRT-Ds. • Stepwise reduction in stroke impedance and stroke volume with increasing heart rate. • The ICI-MF bears potential and requires only a ‘standard’ CRT-D system implantation.
- Published
- 2021